Dr. John Cush RheumNow
4 years 7 months ago
Case showing flare of Dermatomyositis in a Patient With Psoriasis treated with Secukinumab. https://t.co/uvXyqONaHl
Dr. John Cush RheumNow
4 years 7 months ago
Single center study of 957 plaque psoriasis pts and the effect of air pollutants. Overall 39% experience a PSO flare and that concentrations of all pollutants were significantly higher in the 60 days before psoriasis flare https://t.co/8Hw3LsLy8f
Data from the European Alliance of Associations for Rheumatology Coronavirus Vaccine registry shows that patients with with inflammatory or noninflammatory rheumatic and musculoskeletal disease have similar adverse event rates as the general public.
The annual Medscape Physician Burnout & Depression survey has been published for 2022 and Rheumatology burnout stats have improved, now ranking 10th (middle of the pack).
Dr. John Cush RheumNow
4 years 7 months ago
Korean study of 53 424 kids with Kawasaki disease (KD) showed that outbreaks of rhinovirus, respiratory syncytial virus and varicella were significantly correlated with KD at 1 to 3 months before KD outbreaks https://t.co/U8FXao1TWn
Dr. John Cush RheumNow
4 years 7 months ago
Live from Maui! We have a new podcast available for download— RWCS 2022 Roundup
https://t.co/UJRjdPWPmn https://t.co/BIMKdt08kK
MMWR has published the results of the 2017 Behavioral Risk Factor Surveillance System showing that increases in the number of social risk factors independently increases the odds of arthritis and its burden in the USA.
Rheumatoid arthritis (RA) is an autoimmune inflammatory disease of the joints, characterized by pain, swelling, and ultimately, if inadequately treated, joint destruction. Despite recent advances in laboratory testing and imaging, the diagnosis of RA remains a clinical one, according to experts.
Dr. John Cush RheumNow
4 years 7 months ago
Prevent NSAID GI bleeding or perforation? Korean study (n=92K) shows (vs non-prophylaxis) PPI and COX-2 inhibitors associated with 64% and 74% reduced risk. COX2 = PPI +nsNSAID. H2-receptor antag. did not reduce the risk https://t.co/VJX5nAftMf
Dr. John Cush RheumNow
4 years 7 months ago
144 SLE pts from the SLICC cohort were studied showing that a majority (61.2%) scores consistent with depression over 4 yrs; also an inconsistent association between disease activity and depression in multivariate analysis https://t.co/Js5jB6hlox
Dr. John Cush RheumNow
4 years 7 months ago
Watch: Treat to Target Strategy in RA: Dr. Dylan Lee at RWCS22
https://t.co/QExalESU2q https://t.co/cqzL4FYOUl
Dr. John Cush RheumNow
4 years 7 months ago
Watch: COVID-19 Triggered Anti-MDA-5 Antibody: Innocent Bystander or Culprit?
https://t.co/4MtPFM3jvS

